Advances in the molecular characterization of thyroid cancers have fueled the development
of genetic and gene expression‐based tests for thyroid fine‐needle aspirations. Collectively …

The differential diagnosis and malignancy risk stratification of thyroid nodules requires
multidisciplinary expertise and knowledge of both local ultrasonography practices and the …

Objectives Endocrine pathologists are reconsidering whether tumors characterized as
noninvasive follicular variant of papillary thyroid carcinoma (NFVPTC) warrant a diagnosis of …

Background: The diagnostic limitations of thyroid fine-needle aspiration (FNA), such as the
indeterminate category, can be partially overcome by molecular analyses. However, until …

Background: Gene panels are routinely used to assess predisposition to hereditary cancers
by simultaneously testing multiple susceptibility genes and/or variants. More recently …

BACKGROUND Molecular oncology testing is important for patient management, and
requests for the molecular analysis of cytology specimens are increasingly being made …

Purpose To compare mutation analysis of cytology specimens and 99m Tc-MIBI thyroid
scintigraphy for differentiating benign from malignant thyroid nodules in patients with a …

BACKGROUND Molecular testing for genetic alterations associated with malignancy is a
potential triage approach for thyroid fine‐needle aspiration (FNA) samples with …

Background: Previous studies detecting mutations in thyroid nodule fine-needle aspiration
(FNA) material differed with respect to the cytologic grading applied to the FNAs, the type of …

Different genetic mutations and other molecular alterations in papillary thyroid cancer (PTC)
and follicular thyroid cancer (FTC) can be detected in fine-needle aspiration (FNA) of thyroid …